Dsm-firmenich on Thursday beat market expectations for second-quarter core earnings and said full-year sales growth should reach the upper end of its target range on the back of broad-based volume growth.
| Household Products Industry | Consumer Staples Sector | Mr. Dimitri de Vreeze CEO | OTC PINK Exchange | - ISIN |
| US Country | 20,786 Employees | 29 May 2026 Last Dividend | - Last Split | - IPO Date |
DSM-Firmenich AG emerges as a global leader in the fields of beauty, health, and nutrition, with its roots intricately woven into the science-based sectors. Established in 1902 and headquartered in Kaiseraugst, Switzerland, the company has meticulously expanded its footprint across diverse geographies including the Netherlands, the broader European region, North and Latin America, China, and other parts of Asia. Its operations are strategically segmented into four distinct areas: Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage. DSM-Firmenich AG’s core philosophy revolves around leveraging innovative science to make a positive impact on the lives of its customers worldwide, catering to their evolving needs in the realms of aesthetics, wellness, and sustenance.